Non-randomized comparison between irinotecan plus mitomycin C and irinotecan alone in patients with advanced gastric cancer refractory to fluoropyrimidine and platinum.
Authors:
- Akira UedaAUAkira Ueda
- Ayumu HosokawaAHAyumu Hosokawa
- Kohei OgawaKOKohei Ogawa
- Hiroki YoshitaHYHiroki Yoshita
- Hiroshi MiharaHMHiroshi Mihara
- Takayuki AndoTATakayuki Ando
- Shinya KajiuraSKShinya Kajiura
- Haruka FujinamiHFHaruka Fujinami
- Jun NishikawaJNJun Nishikawa
- Masami MinemuraMMMasami Minemura
- Mitsuhiro TeradaMTMitsuhiro Terada
- Takashi KobayashiTKTakashi Kobayashi
- 1 November 2013
- journal article
- research article
- Vol. 33 (11) , 5107-11